Altre lingue BioSig Technologies, Inc.

Azioni

BSGM

US09073N3008

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
1,37 ^USD	+5,38%		-2,84%	-71,16%

16/04	BioSig Technologies, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
28/02	Biosig Technologies, Inc. annuncia le dimissioni di Kenneth L. Londoner da Amministratore Delegato	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioSig Technologies : Annual report pursuant to Section 13 and 15(d)	16/04
BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
BioSig Engages Consulting Firm for Business Model Strategies	04/04
BioSig Technologies : Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	02/04
BioSig Technologies : Failure to Satisfy Listing Rule - Form 8-K	18/03
BioSig Technologies Inc. Issues Promissory Note to an Investor for $500,000	12/03
BioSig Technologies, Inc. announced that it has received $0.5 million in funding	07/03
Biosig Technologies, Inc. Announces Resignation of Kenneth L. Londoner as Chief Executive Officer	28/02
BioSig Technologies, Inc. Announces Executive Changes	28/02
Steve Buhaly Resigns as Chief Financial Officer of Biosig Technologies, Inc	21/02
Biosig Technologies, Inc. Announces Directorate Resignations	21/02
BioSig Announces Reduction of its Workforce	20/02
BioSig Announces Reduction of its Workforce	20/02
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases	06/02
Biosig Technologies, Inc. Commences Workforce Reduction Consisted of the Departure of Sixteen Employees	01/02
BioSig Technologies, Inc. Announces Executive Departures	01/02
BioSig Technologies Undertaking 1-for-10 Reverse Stock Split	31/01
BioSig Announces Reverse Stock Split	31/01
BioSig Announces Reverse Stock Split	31/01
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy	30/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioSig Technologies, Inc.

Azioni

BSGM

US09073N3008

Altre lingue

Filtri